Cara Vivarelli-O'Neill, MPH’s Post

One of today’s sessions at #TOPRASYM24 focused on the complexity of clinical trial innovation across borders and the evolution of regulatory infrastructure in Europe as alignment initiatives continue. The bottom line: it takes time to do it right—and honest conversations between regulatory authorities and companies to put patients first. The good news: trust is being built and progress is happening through transparent stakeholder collaborations. Well done, Maren Koban, Susan Bhatti, Lada Leyens, Katarina Nedog, Kit Roes, Begoña Nafría Escalera and Ana Zanoletty.

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics